Thrombinogenesis in chronic myeloproliferative syndromes;Trombinogeneza w przewlekłych zespołach mieloproliferacyjnych

Polski Merkuriusz Lekarski

Volumn 20, Issue 120, 2006, Pages 717-720

  Rość, Danuta ^a,e   Kremplewska Nalezyta, Elzbieta ^b,c   Gadomska, Grazyna ^b,d   Kowalewska, Anita ^a   Buczkowska, Elzbieta ^a  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^b Wojewódzka Poradnia Hematologiczna ^*

^c Province Hematology Outpatient Clinic   (Poland)

^d Department of Hematology and Internal Diseases   (Poland)

^e Katedra i Zakad Patofizjologii   (Poland)

Author keywords

Chronic myeloproliferative syndromes; Thrombinogenesis

Indexed keywords

THROMBIN ANTITHROMBIN COMPLEX;

CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; MYELOFIBROSIS; MYELOPROLIFERATIVE DISORDER; POLYCYTHEMIA VERA; REVIEW; RISK ASSESSMENT; THROMBOCYTHEMIA; THROMBOSIS;

ADULT; AGED; CHRONIC DISEASE; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; LEUKEMIA, MYELOID, CHRONIC; MALE; MIDDLE AGED; POLYCYTHEMIA VERA; THROMBOCYTOSIS; THROMBOSIS;

EID: 33746152416     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (18)

1. Barbui T., Cortelazzo S., Viero P. i wsp.: Thrombohaemorrhagic complications in 101 cases of myeloproliferative disorders: relationship to platelet number and function. Eur. J. Cancer. Oncol. 1983, 19, 1593-1599.
2. Gabazza E.C., Taguchi O., Yamakami T. i wsp.: Coagulation-fibrinolysis system and markers of collagen metabolism in lung cancer. Cancer, 1992, 70, 2631-2636.
3. Gordon S.G.: Cancer cell procoagulant and their role in malignant disease. Semin. Thromb. Hemost. 1992, 18, 424-433.
4. Landolfi R., Marchioli R., Patrono C.: Mechanism of bleeding and thrombosis in myeloproliferative disorders. Thromb. Haemost. 1997, 78, 617-621.
5. Olas B., Wachowicz B.: Rola trombiny w hemostazie. Post. Hig. Med. Dośw., 1998, 52, 471-478.
6. Patterson W.P., Caldwell C.W., Doll D.C.: Hyperviscosity syndromes and coagulopathies. Semin. Oncol., 1990, 17, 210-216.
7. Pearson T.C.: Primary thrombocythemia: diagnosis and management. Br. J. Haematol., 1991, 78, 145-148.
8. Pritchard K.I., Paterson A.H., Paul N.A. i wsp.: Increased thromboembolic complications with concurrent tamoxifen and chemotherapy in a randomized trial of adjuvant therapy for women with breast cancer. National Cancer Institute of Canada Clinical Trials Group, Breast Cancer Site Group. J. Clin. Oncol., 1996, 14, 2731-2737.
9. Raszeja-Specht A., Skibowska A., Kabata J. i wsp.: Zaburzenia płytkowe w przewlekłych zespołach mieloproliferacyjnych. Acta Haemat. Pol., 1994, 25, 253-259.
10. Reinthaller A., Mursch-Edlmayr G., Tatra G.: Thrombin antithrombin III complex levels in normal pregnancy with hypertensive disorders and after delivery. Br. J. Obset. Gynecol., 1990, 97, 506-510.
11. Rość D., Kotschy M., Rewakowicz M., Listopadzki D.: Thrombin-antithrombin complex in patients with peripheral occlusive arterial disease. Folia Haemat., 1990, 117, 405.
12. Wagner C., Dati F., Pelzer H., Seitz R.: A new marker of in vivo activation of the coagulation system: thrombin- antithrombin III complex. Proc. of Int. Meet. Danaubian League Against Thromb. Haemorrh. Dis., Vienna, 1989, 161-165.
13. Wehmeier A., Danm I., Jamin H. i wsp.: Incidence and clinical risk factors for bleeding and thrombotic complications in myeloproliferative disorders. A retrospective analysis of 260 patients. Ann. Hematol., 1991, 63, 101-106.
14. Wehmeier A., Scharf R.E., Flicke S. i wsp.: Bleeding and thrombosis in chronic myeloproliferative disorders: relation of platelet disorders to clinical aspects of the disease. Haemostasis, 1989, 19, 251-259.
15. van-Wersch J.W., Ubaschs J.M.: Blood coagulation and fibrinolysis during normal pregnancy. Eur. J. Clin. Chem. Biochem., 1991, 29, 45-50.
16. Wojtukiewicz M.Z.: Kliniczne aspekty aktywacji krzepniȩcia krwi w chorobie nowotworowej. Acta Haemat. Pol., 1997, 28, supl. 1, 79-93.
17. Wojtukiewicz M.Z., Zacharski L.R., Memoli V.A. i wsp.: Indirect activation of coagulation and fibrinolysis pathways in colon cancer. Thromb. Haemost., 1989, 62, 1062-1066.
18. Zawilska K.: Markery wewna̧trznaczyniowej aktywacji krzepniȩcia. Acta Haemat. Pol. 1994, 25, supl. 2, 27-33.